-
-
Small Molecule Drug Platform
-
Chiral Catalysis Technology
-
Continuous Flow Technology
-
Fluorine Chemistry
-
Enzyme Catalysis
-
Photocatalysis
-
Solid-State Research
显示更多 -
-
Drug Product (DP) Platforms
-
Sustained and Controlled Release
-
Solubility Enhancement
-
Topical Formulation
-
Liquid Formulation
-
Softgels
-
Flow-through cell
显示更多 -
-
Peptide Platform
显示更多 -
Research Team
显示更多
-
Service Platform
Related Services and Solutions
We look forward to working with you and providing you with excellent service.
Drug Product CDMO Services
Jiuzhou Pharma provides customers with one-stop CDMO services throughout the full lifecycle of drug products, from dosage form design, formulation process R&D, quality studies, stability testing, to commercial production.
Kangchuanji Pharmatech, a Jiuzhou Pharma subsidiary led by Professor Yin Lifang of China Pharmaceutical University, has a core team of experts with decades of R&D experience. The team is capable of pharmaceutical research on various dosage forms, leveraging multiple key technological platforms for delivery systems, including sustained and controlled release, solubility enhancement, topical formulations, liquid doses, softgels, and oral fast dissolving technology.
One-stop DP CDMO services
Flexible, robust pilot scale-up facilities enable seamless transition from preclinical R&D to commercialization
Business Collaboration
Innovative Drug CDMO Services